Successful eradication of mucormycosis occurring in a pulmonary allograft

David A. Hunstad, Alan H. Cohen, Joseph W. St. Geme

Research output: Contribution to journalArticle

Abstract

The zygomycetes are saprophytic fungi that rarely cause disease in the normal human host. In immunocompromised individuals, these organisms can cause invasive infections, collectively called mucormycosis. Mucormycosis is associated with a high mortality rate, especially in organ transplant recipients. In this report, we describe the first case of successfully treated mucormycosis involving a pulmonary allograft. Treatment consisted of surgical excision of the affected lobe and chest wall and lipid-complex amphotericin B. The lipid complex formulation permitted a prolonged course of therapy that was likely critical to eradication of the infection. Copyright (C) 1999 International Society for Heart and Lung Transplantation.

Original languageEnglish (US)
Pages (from-to)801-804
Number of pages4
JournalJournal of Heart and Lung Transplantation
Volume18
Issue number8
DOIs
StatePublished - Aug 1999
Externally publishedYes

Fingerprint

Mucormycosis
Allografts
Lung
Thoracic Wall
Infection
Fungi
Transplants
Lipids
Mortality
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Transplantation

Cite this

Successful eradication of mucormycosis occurring in a pulmonary allograft. / Hunstad, David A.; Cohen, Alan H.; St. Geme, Joseph W.

In: Journal of Heart and Lung Transplantation, Vol. 18, No. 8, 08.1999, p. 801-804.

Research output: Contribution to journalArticle

Hunstad, David A. ; Cohen, Alan H. ; St. Geme, Joseph W. / Successful eradication of mucormycosis occurring in a pulmonary allograft. In: Journal of Heart and Lung Transplantation. 1999 ; Vol. 18, No. 8. pp. 801-804.
@article{47af79e686fb4eecb939343e6135dd70,
title = "Successful eradication of mucormycosis occurring in a pulmonary allograft",
abstract = "The zygomycetes are saprophytic fungi that rarely cause disease in the normal human host. In immunocompromised individuals, these organisms can cause invasive infections, collectively called mucormycosis. Mucormycosis is associated with a high mortality rate, especially in organ transplant recipients. In this report, we describe the first case of successfully treated mucormycosis involving a pulmonary allograft. Treatment consisted of surgical excision of the affected lobe and chest wall and lipid-complex amphotericin B. The lipid complex formulation permitted a prolonged course of therapy that was likely critical to eradication of the infection. Copyright (C) 1999 International Society for Heart and Lung Transplantation.",
author = "Hunstad, {David A.} and Cohen, {Alan H.} and {St. Geme}, {Joseph W.}",
year = "1999",
month = "8",
doi = "10.1016/S1053-2498(99)00033-9",
language = "English (US)",
volume = "18",
pages = "801--804",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "8",

}

TY - JOUR

T1 - Successful eradication of mucormycosis occurring in a pulmonary allograft

AU - Hunstad, David A.

AU - Cohen, Alan H.

AU - St. Geme, Joseph W.

PY - 1999/8

Y1 - 1999/8

N2 - The zygomycetes are saprophytic fungi that rarely cause disease in the normal human host. In immunocompromised individuals, these organisms can cause invasive infections, collectively called mucormycosis. Mucormycosis is associated with a high mortality rate, especially in organ transplant recipients. In this report, we describe the first case of successfully treated mucormycosis involving a pulmonary allograft. Treatment consisted of surgical excision of the affected lobe and chest wall and lipid-complex amphotericin B. The lipid complex formulation permitted a prolonged course of therapy that was likely critical to eradication of the infection. Copyright (C) 1999 International Society for Heart and Lung Transplantation.

AB - The zygomycetes are saprophytic fungi that rarely cause disease in the normal human host. In immunocompromised individuals, these organisms can cause invasive infections, collectively called mucormycosis. Mucormycosis is associated with a high mortality rate, especially in organ transplant recipients. In this report, we describe the first case of successfully treated mucormycosis involving a pulmonary allograft. Treatment consisted of surgical excision of the affected lobe and chest wall and lipid-complex amphotericin B. The lipid complex formulation permitted a prolonged course of therapy that was likely critical to eradication of the infection. Copyright (C) 1999 International Society for Heart and Lung Transplantation.

UR - http://www.scopus.com/inward/record.url?scp=0032833724&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032833724&partnerID=8YFLogxK

U2 - 10.1016/S1053-2498(99)00033-9

DO - 10.1016/S1053-2498(99)00033-9

M3 - Article

C2 - 10512529

AN - SCOPUS:0032833724

VL - 18

SP - 801

EP - 804

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 8

ER -